ReviewHuman genomics2025
Early mutational events and clonal dynamics in normal crypts: implications for colorectal tumorigenesis.
Review in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The CXCL12-CXCR4 axis in colorectal cancer: immune regulation, metastatic progression, and therapeutic implications.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer has widely been described by the classic adenoma-carcinoma sequence, where sequential mutations in APC, KRAS, and TP53 drive the transition from normal epithelium to carcinoma. However, recent high-resolution genomic analyses have expanded this framework by revealing the presence of multiple driver mutations within morphologically normal colonic crypts. In this review, we summarize the emerging landscape of several somatic driver mutations in normal crypts, highlighting genes that were reported to be under positive selection, such as FBXW7, STAG2, AXIN2, PIK3CA, ERBB2, and ERBB3, and discuss their known functions in both normal epithelium and colorectal cancer. We also postulate the functional consequences of these mutations in the overall priming of colonic crypts to potential tumorigenesis. Despite their presence, the frequencies of these mutations in both normal epithelial and colorectal cancers are low, and most of them do not progress to malignancy. We therefore discuss the intrinsic and extrinsic factors that dictate the fate of these crypts. Together, these findings underscore that tumor-initiating events in colorectal cancer may occur much earlier than previously recognized. A deeper understanding of these early driver events may help to better inform strategies for early detection, risk stratification, and prevention before these morphologically normal crypts transform into neoplasia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.